View All Key Stats
ACET Key Stats
| Income Statement | |
| Revenue (TTM) | 638.32M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.34 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 11.38M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 18.92% |
| Profit Margin (Quarterly) | 1.01% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 2.32% |
| Price and Valuation | |
| Market Cap | 337.53M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 0.5713 |
| PE Ratio (TTM) | 32.97 |
| Price to Book Value | 0.8280 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.8675 |
| Free Cash Flow (Quarterly) | 12.23M |
| Return on Equity (TTM) | 3.12% |
View All ACET News
ACET News
-
WireHeadlineTime (ET)
-
Yahoo09/07 07:40
-
Globe Newswire09/05 08:54
-
Yahoo09/01 18:41
-
Yahoo08/31 08:37
-
Yahoo08/29 11:45
-
Yahoo08/28 09:57
-
Yahoo08/27 18:05
-
MT Newswires08/25 16:01
-
MT Newswires08/25 15:53
-
MT Newswires08/25 14:12
View All Events
ACET Events
| Date | Type | Description |
|---|---|---|
| 08/25/2017 09:00 EDT | Misc | Aceto Corp Fourth Quarter Earnings Conference Call in 2017 |
| 08/24/2017 | Earnings | Aceto Corp Fourth Quarter Earnings Results in 2017 |
| 06/07/2017 | Dividends | Amount: 0.065, Declared Date: May 06 2017, Pay Date: Jun 23 2017 |
| 05/05/2017 09:00 EDT | Misc | Aceto Corp Third Quarter Earnings Conference Call in 2017 |
| 05/04/2017 | Earnings | Aceto Corp Third Quarter Earnings in 2017 Release |
| 03/08/2017 | Dividends | Amount: 0.065, Declared Date: Feb 02 2017, Pay Date: Mar 24 2017 |
| 02/03/2017 09:00 EST | Misc | Aceto Corp Second Quarter Earnings Conference Call in 2017 |
| 02/02/2017 | Earnings | Aceto Corp Second Quarter Earnings in 2017 Release |
| 12/21/2016 | Misc | Aceto Completes Acquisition of Generic Products and Related Assets of Citron Pharma and Lucid Pharma |
| 12/08/2016 | Dividends | Amount: 0.065, Declared Date: Dec 01 2016, Pay Date: Dec 22 2016 |
ACET Fundamentals
Income Statement View Statement
ACET Ratings
Advertisement
ACET One Page Reports
- One Page Report Download
ACET Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 11.21 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.aceto.com
- Investor Relations URL: http://investor.aceto.com/phoenix.zhtml?c=79500&p=irol-irhome
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 24, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Jun. 07, 2017
- Description: Aceto Corp is engaged in the marketing, sells and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, and specialty performance chemicals.
ACET Comparables
EditACET Excel Add-In Codes
- Name: =YCI("ACET","name")
- Description: =YCI("ACET","description")
- Sector: =YCI("ACET","sector")
- Industry: =YCI("ACET","industry")
- Est. Current Fiscal Year End: =YCI("ACET","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ACET Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ACET Tweets Stocktwits
Advertisement
